Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

NCT03975049 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

933

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Chemotherapy Effect

Interventions

RADIATION: Chemoradiation
DRUG: FOLFOXIRI Protocol
DRUG: Folfox Protocol

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University